Renaissance Capital logo

ISPC News

US IPO Weekly Recap: IPO market in full swing as biotechs lead a 16 IPO week

LYEL

The IPO market was in full swing this past week as 16 IPOs and six SPACs went public. The IPO pipeline cooled down with just one IPO and nine SPACs submitting initial filings. The largest deal of the week, Lyell Immunopharma (LYEL) priced at the midpoint to raise $425 million at a $4.7 billion market cap. The company is using proprietary genetic and...read more

Biospecimen marketplace iSpecimen prices $18 million IPO at $8 low end

ISPC

iSpecimen, which provides an online marketplace platform for biospecimen procurement, raised $18 million by offering 2.25 million shares at $8, the low end of the range of $8 to $10. At pricing, the company commands a fully diluted market value of about $52 million. During the 1Q21, iSpecimen's revenue increased 73% to $3 million, while its operating loss widened to -$0.9...read more

Online biospecimen marketplace iSpecimen sets terms for $20 million IPO

ISPC

iSpecimen, which provides an online marketplace platform for biospecimen procurement, announced terms for its IPO on Monday. The Lexington, MA-based company plans to raise $20 million by offering 2.2 million shares at a price range of $8 to $10. At the midpoint of the proposed range, iSpecimen would command a fully diluted market value of $57 million. The company hopes to...read more

Online biospecimen marketplace iSpecimen files for a $21 million IPO

ISPN.RC

iSpecimen, which provides an online marketplace platform for biospecimen procurement, filed on Thursday with the SEC to raise up to $21 million in an initial public offering. The company hopes to accelerate life science research and development with a global marketplace platform that connects researchers to subjects, specimens, and associated data. Its current customer base is...read more

Archived Headlines